Question 72

Mercaptopurine is considered to be a high-alert medication.

High-alert medications are those that have a heightened risk of causing significant harm when they are used in error. Mercaptopurine is classified as a high-alert medication due to its potential for severe side effects and the need for careful monitoring during treatment.

A) Meloxicam

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation. While it can have side effects, it is not classified as a high-alert medication because the risks associated with its use are generally lower compared to those of Mercaptopurine.

B) Mercaptopurine

Mercaptopurine is an antimetabolite used primarily in the treatment of certain cancers and autoimmune diseases. It is considered a high-alert medication because incorrect dosing can lead to serious toxicity, including bone marrow suppression and increased risk of infections, necessitating careful management and monitoring.

C) Metronidazole

Metronidazole is an antibiotic used to treat various infections. Although it can cause adverse effects, it is not classified as a high-alert medication. The risks associated with its use are typically manageable and do not require the same level of monitoring as Mercaptopurine.

D) Methocarbamol

Methocarbamol is a muscle relaxant used to treat muscle spasms and pain. It is not considered a high-alert medication; the safety profile of Methocarbamol does not warrant the heightened precautions that are necessary for medications like Mercaptopurine.

Conclusion

Mercaptopurine is definitively identified as a high-alert medication due to its potential for severe adverse effects and the critical need for monitoring. In contrast, Meloxicam, Metronidazole, and Methocarbamol do not carry the same level of risk, making them less critical in terms of monitoring and management. Understanding the classification of medications is essential for ensuring patient safety in pharmacotherapy.